SHSE:688468 (China)
Â
Class A
Â¥
5.59
-0.13 (-2.27%)
Jul 24
Business Description
Chemclin Diagnostics Co Ltd
ISIN : CNE100005311
Share Class Description:
SHSE:688468: Class ATotal Employee Number:
580Compare
Compare
Traded in other countries / regions
688468.China Index Membership
SSE Composite Index IPO Date
2021-04-09Description
Chemclin Diagnostics Co Ltd is engaged in the development, production and sales of clinical immunochemiluminescence diagnostic testing reagents and instruments.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.67 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | 4.48 | |||||
Interest Coverage | 6.77 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.22 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -10.4 | |||||
3-Year EBITDA Growth Rate | -20.9 | |||||
3-Year EPS without NRI Growth Rate | -38.4 | |||||
3-Year FCF Growth Rate | -41.3 | |||||
3-Year Book Growth Rate | 0.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.6 | |||||
9-Day RSI | 38.49 | |||||
14-Day RSI | 39.7 | |||||
3-1 Month Momentum % | -15.56 | |||||
6-1 Month Momentum % | -25.94 | |||||
12-1 Month Momentum % | -20.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.77 | |||||
Quick Ratio | 4.06 | |||||
Cash Ratio | 2.5 | |||||
Days Inventory | 361.29 | |||||
Days Sales Outstanding | 17.67 | |||||
Days Payable | 87.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.27 | |||||
Dividend Payout Ratio | 1.21 | |||||
3-Year Dividend Growth Rate | -9.7 | |||||
5-Year Yield-on-Cost % | 2.27 | |||||
Shareholder Yield % | 2.56 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 65.25 | |||||
Operating Margin % | 12.73 | |||||
Net Margin % | 11.8 | |||||
EBITDA Margin % | 15.98 | |||||
FCF Margin % | 19.1 | |||||
OCF Margin % | 31.76 | |||||
ROE % | 2.71 | |||||
ROA % | 2.16 | |||||
ROIC % | 3.47 | |||||
3-Year ROIIC % | -10.67 | |||||
ROC (Joel Greenblatt) % | 8.7 | |||||
ROCE % | 3.19 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 62.11 | |||||
PE Ratio without NRI | 54.27 | |||||
PS Ratio | 7.22 | |||||
PB Ratio | 1.58 | |||||
Price-to-Tangible-Book | 1.83 | |||||
Price-to-Free-Cash-Flow | 37.99 | |||||
Price-to-Operating-Cash-Flow | 22.65 | |||||
EV-to-EBIT | 39.43 | |||||
EV-to-EBITDA | 39.43 | |||||
EV-to-Revenue | 6.3 | |||||
EV-to-FCF | 32.99 | |||||
Price-to-GF-Value | 0.97 | |||||
Price-to-Projected-FCF | 1.61 | |||||
Price-to-Graham-Number | 2.09 | |||||
| Price-to-Net-Current-Asset-Value | 5.65 | |||||
| Price-to-Net-Cash | 50.82 | |||||
Earnings Yield (Greenblatt) % | 2.54 | |||||
FCF Yield % | 2.77 | |||||
Forward Rate of Return (Yacktman) % | -21.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chemclin Diagnostics Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 324.725 | ||
| EPS (TTM) (Â¥) | 0.09 | ||
| Beta | 1.042 | ||
| 3-Year Sharpe Ratio | -0.59 | ||
| 3-Year Sortino Ratio | -0.69 | ||
| Volatility % | 25.17 | ||
| 14-Day RSI | 39.7 | ||
| 14-Day ATR (Â¥) | 0.238345 | ||
| 20-Day SMA (Â¥) | 5.9465 | ||
| 12-1 Month Momentum % | -20.73 | ||
| 52-Week Range (Â¥) | 5.53 - 9.12 | ||
| Shares Outstanding (Mil) | 401.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chemclin Diagnostics Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chemclin Diagnostics Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.125000 Cash Dividend | 2025-06-13 | 7.43 (+0.68%) |
Show
Entries
Chemclin Diagnostics Co Ltd Frequently Asked Questions
What is Chemclin Diagnostics Co Ltd(SHSE:688468)'s stock price today?
The current price of SHSE:688468 is ¥5.59. The 52 week high of SHSE:688468 is ¥9.12 and 52 week low is ¥5.53.
When is next earnings date of Chemclin Diagnostics Co Ltd(SHSE:688468)?
The next earnings date of Chemclin Diagnostics Co Ltd(SHSE:688468) is .
Does Chemclin Diagnostics Co Ltd(SHSE:688468) pay dividends? If so, how much?
The Dividend Yield %  of Chemclin Diagnostics Co Ltd(SHSE:688468) is 2.27% (As of Today), Highest Dividend Payout Ratio of Chemclin Diagnostics Co Ltd(SHSE:688468) was 1.79. The lowest was 0.5. And the median was 0.86. The  Forward Dividend Yield % of Chemclin Diagnostics Co Ltd(SHSE:688468) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Chemclin Diagnostics Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers